Chagas disease: chronic Chagas cardiomyopathy

NG Echavarria, LE Echeverría, M Stewart… - Current problems in …, 2021 - Elsevier
Chagas disease (CD) is a tropical vector-borne infection caused by the protozoan parasite
Trypanosoma cruzi (T. cruzi), also known as American Trypanosomiasis. It is considered …

Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta‐analysis

S Chadalawada, A Rassi Jr, O Samara… - ESC Heart …, 2021 - Wiley Online Library
Aims This study aimed to estimate the annual mortality risk and its determinants in chronic
Chagas cardiomyopathy. Methods and results We conducted a systematic search in …

SBC guideline on the diagnosis and treatment of patients with cardiomyopathy of chagas disease–2023

JA Marin-Neto, A Rassi Jr, GMM Oliveira… - Arquivos Brasileiros …, 2023 - SciELO Brasil
SciELO - Brazil - Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com
Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e Tratamento …

Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas–2023

JA Marin-Neto, A Rassi Jr, GMM Oliveira… - Arquivos Brasileiros …, 2023 - SciELO Brasil
A DC (tripanossomíase americana) é entidade mórbida transmissível, potencialmente fatal,
causada pelo protozoário parasita T. cruzi e que integra o grupo de doenças tropicais …

[HTML][HTML] WHF recommendations for the use of echocardiography in chagas disease

K Ralston, E Zaidel, H Acquatella, MM Barbosa… - Global Heart, 2023 - ncbi.nlm.nih.gov
Chagas disease (ChD) represents a significant health burden in endemic regions of Latin
America and is increasingly being recognized as a global health issue. The cardiac …

[HTML][HTML] Prognostic Evaluation of Chagasic and Non-Chagasic Patients Undergoing Pacemaker Implantation and Cardiac Resynchronization in a Tertiary Center

LT Vasconcelos, LNA Martins, AT França… - Arquivos Brasileiros …, 2024 - SciELO Brasil
Fundamento: A cardiomiopatia chagásica (CCh) é responsável pelo implante de marca-
passo (MP) em muitos pacientes, tendo sido associada a prognóstico adverso. Objetivos …

The usefulness of patient-reported outcome measures in decision making in Chagas cardiomyopathy: a scoping review

WT Silva, KLS Silva, DM Xavier… - Transactions of The …, 2024 - academic.oup.com
Chagas cardiomyopathy (ChC) presents many biopsychosocial complexities, highlighting
the need to have patient self-report questions. This study demonstrates the scope of the use …

Left Bundle Branch Area Pacing for Resynchronization in Chagasic Patient and Dependent on Artificial Cardiac Pacing. Case Report

RC Galvão, JPV Pucci, OG Vieira… - Arquivos Brasileiros …, 2023 - SciELO Brasil
Persistent monosytic pacing of the right ventricle can cause deleterious effects on ventricular
function. 1 Patients with Chagas cardiomyopathy (CCM) with ventricular dysfunction …

Prognóstico de Pacientes Chagásicos e não Chagásicos Submetidos a Implante de Marca-passo e Ressincronizador Cardíaco em Centro Terciário

LT Vasconcelos, LNA Martins, AT França… - Arquivos Brasileiros …, 2024 - SciELO Brasil
Fundamento: A cardiomiopatia chagásica (CCh) é responsável pelo implante de marca-
passo (MP) em muitos pacientes, tendo sido associada a prognóstico adverso. Objetivos …

Diretriz da Sociedade Brasileira de Cardiologia sobre diagnóstico e tratamento de pacientes com cardiomiopatia da doença de Chagas

JA Marin-Neto, A Rassi Jr, GMM Oliveira, LCL Correia… - 2022 - preprints.scielo.org
This guideline aimed to update the concepts and formulate the standards of conduct and
scientific evidence that support them, regarding the diagnosis and treatment of the …